Galectin Therapeutics Inc (NASDAQ:GALT)

2.73
BATS BZX Real-Time Price
As of 3:51pm ET
 +0.02 / +0.74%
Today’s Change
2.61
Today|||52-Week Range
16.55
-21.33%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close2.71
Today’s open2.70
Day’s range2.66 - 2.77
Volume46,939
Average volume (3 months)101,685
Market cap$64.3M
Dividend yield--
Data as of 3:36pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)+2.56%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
AVDXAvant Diagnostics In...-0.04-7.25%
GBSNUGreat Basin Scientif...0.000.00%
GBIMGlobeImmune Inc-0.30-3.98%
TROVUTrovagene Inc0.000.00%
Data as of 3:25pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers